Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review - Wikidata - awgldk - TriplyDB

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review

http://www.wikidata.org/entity/Q28297302

about

State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring.Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C.Tailored combination prevention packages and PrEP for young key populations.Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern A needle in the haystack--the dire straits of needle exchange in Hungary.Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews The micro-social risk environment for injection drug use: An event specific analysis of dyadic, situational, and network predictors of injection risk behavior.The Use of Illegal Drugs and Infectious Contagious Diseases: Knowledge and Intervention among Dockworkers.Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.Drug preparation, injection, and sharing practices in Tajikistan: a qualitative study in Kulob and Khorog The case of a needle exchange policy debate in Fresno, California HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.Novel interventions to prevent HIV and HCV among persons who inject drugs.Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.The effect of prevention methods on reducing sexual risk for HIV and their potential impact on a large-scale: a literature review.Mobilising a global response to hepatitis: Lessons learned from the HIV movement.Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.Syringe Stockpiling by Persons Who Inject Drugs: An Evaluation of Current Measures for Needle and Syringe Program Coverage.Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles.Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approach.HIV and adolescents: focus on young key populations.Pence, Putin, Mbeki and Their HIV/AIDS-Related Crimes Against Humanity: Call for Social Justice and Behavioral Science Advocacy.Communication Strategies to Counter Stigma and Improve Mental Illness and Substance Use Disorder Policy.HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact.Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007 Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012 The discordance between evidence and health policy in the United States: the science of translational research and the critical role of diverse stakeholders

P2860

Q28255620-668449C8-678A-4CC4-87A9-E9FCBE5CFECE Q28608358-47696A02-E508-4873-8344-B24CF95DBDC1 Q30249677-78D54857-338D-48AC-86F4-30AE52D0B272 Q30249830-37C20179-7998-4950-B9AA-A86954F07414 Q33592665-669E919E-937E-4250-BA0C-6E59794869E1 Q33702754-F856A335-ED94-4520-A47A-C2564413EEB8 Q34260694-09A806B0-7A2B-4E4F-B85F-AACCCECF4473 Q35131207-11A5AA56-D712-41E3-BB01-B360E33C9386 Q35823557-6D5C11D7-F2B5-4E1A-A003-46A0D25A1CDF Q35924703-EEB48F80-90B2-4CFD-AF9F-5614185EE3AB Q35998417-C58A077D-BFA6-4DDD-885B-06D6B25F44B2 Q36343824-EA0D8A38-C92B-4EC4-B4D1-02364A833DB6 Q36471464-E42D5951-4F0D-4D4D-B316-99E7672815BF Q36513278-66B8AECA-1128-4A46-A347-6E4FAF913E9F Q36641585-C19A26E5-425C-4330-A1CA-C9EE2756C23D Q36669743-F706A1DE-C436-4B75-A403-2FF2E320F877 Q36960123-35EAEAF7-7A9C-445C-8818-9DC84600C282 Q37536378-2DF7BA13-E140-440A-A91D-353F4E7345D8 Q37671864-D10BB14D-29F2-4DC1-BE82-B39609C6A4ED Q38318678-5BB584C5-8405-4AFC-B830-AB7BCC6E2B12 Q38334024-5C05FF38-45A6-4DEC-87A7-F9B075B90959 Q38656815-B56E3EE3-10C0-4A81-8E90-A896E65F5F93 Q38810895-A36B3C15-5E45-46DA-B712-F3A345189AEA Q38827011-696278EA-6975-4B1F-8D43-F9F71E35E8BA Q39860271-006C50CF-CC53-44E0-BF10-52B9E27DDBCB Q40176014-0DEB6650-2EF9-4081-A377-689744F83944 Q40232737-00CB1C0E-C4BA-447A-91A5-17B4C764712E Q41713792-74B0F52C-0756-438C-AC1E-79C4DD7CC6F7 Q46119171-6FE80D4A-4D9A-47B5-BA9D-D792613D0C02 Q46626986-9BC7D33C-B6BC-47E1-BB2F-12D448E98996 Q47255324-D11633E4-DD5E-4C3B-8966-7D69D6626025 Q47555256-11A5000A-9FA7-48B0-8595-49EBDFDC40F3 Q47570818-976F3947-EE3B-4C6D-B364-9540AF7A5D8F Q50107361-B298D6B8-46A9-48AD-92A9-2EEB95569753 Q50217902-8746A585-EC02-494D-A990-4CB035C7B1B7 Q57170187-C9E12A7D-1256-414D-BD2E-4EF30A6A0BBC Q57193075-E866EC60-C268-46A7-9999-CE8CF3A5FD2B Q57211847-6F3B63DE-D8D1-4580-8578-92395D7DEC5A Q58774096-F36F0654-CCB5-4E6C-921B-520C60936F90

P2860

Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review

http://www.wikidata.org/entity/Q28297302

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Effectiveness of structural-le ...... ect drugs: a systematic review

@ast

Effectiveness of structural-le ...... ect drugs: a systematic review

@en

Effectiveness of structural-le ...... ect drugs: a systematic review

@nl

type

label

Effectiveness of structural-le ...... ect drugs: a systematic review

@ast

Effectiveness of structural-le ...... ect drugs: a systematic review

@en

Effectiveness of structural-le ...... ect drugs: a systematic review

@nl

prefLabel

Effectiveness of structural-le ...... ect drugs: a systematic review

@ast

Effectiveness of structural-le ...... ect drugs: a systematic review

@en

Effectiveness of structural-le ...... ect drugs: a systematic review

@nl

P1433

Q28297302-ED1AEB63-0B0E-4665-8940-A4D054E9BF4A

P1476

Q28297302-E8229800-99F8-494C-AAFA-C324109142CC

P2093

Q28297302-2F8FDE7D-E301-4624-AEE5-0184391D01F2

Q28297302-7B317944-0BD7-4F73-964D-D40C6B382E31

Q28297302-A8B07B4B-E453-458F-B08F-19C8FC5C43AA

Q28297302-B39FAE94-0DCC-4142-A83E-6C15116DC9D5

Q28297302-B7084830-CDAA-4154-9407-5ECD856FF538

Q28297302-CA1CF9F3-E2A7-43A4-B9D9-E833FD13EAD2

Q28297302-E31587E5-1C1D-4389-826F-9BE39B638DA7

Q28297302-F6CAF54F-8F7F-47BC-B5AB-3FDF94F77D4B

P2860

Q28297302-002AE170-F9B5-4175-B592-5399319963BC

Q28297302-02CFA54B-0A81-4190-ABE7-DF4450073C8B

Q28297302-0BB4BEB2-BC0C-4036-84C5-17E554636C76

Q28297302-1685E2A8-C129-4831-831F-FB851167B306

Q28297302-191F4210-12AC-4F9A-81D0-99DA840E7A09

Q28297302-222BAEEC-E64D-4DFD-B996-2F800CB8F279

Q28297302-451F2BF4-6A1A-4F92-A42C-04133A8BCB28

Q28297302-4D39FF4F-79F3-4164-96BD-69C206CEA075

Q28297302-5540F1CC-4992-4A14-9B04-04D93DBEC11D

Q28297302-555FA87D-F12B-4989-872A-72DE4CEC8AE6

P2888

Q28297302-A4DCAC56-CB15-4559-8EF1-01512CDAA09A

P304

Q28297302-8CD2D3D6-6380-434E-8AAB-C24EA34C64E4

P31

Q28297302-04F97A10-45E2-4042-9859-27EC3839D90A

Q28297302-C0E46C38-63C5-4BB7-98E3-086552F80339

P3181

Q28297302-0BAB48E6-F098-4A01-B38A-0E1AB69E17C3

P356

Q28297302-A592F087-F91D-4C84-8A1A-C79CED261A70

P407

Q28297302-E5097DC1-E293-4A1E-9B44-A8225986B4ED

P433

Q28297302-F79F994F-CDE4-4650-967C-17F0328F55D6

P478

Q28297302-E2AE9FBA-9ED9-40CB-8CCE-8A3EBB44FF20

P50

Q28297302-2A0F8245-7B4D-429D-B9ED-7B21178EE3D0

P577

Q28297302-1436FD21-A8DE-4004-8E6B-8D83851CA013

P5875

Q28297302-31FC49A6-E339-4221-9A90-D7A1038B24C6

P698

Q28297302-CEB4B619-F5F2-4F66-AF9E-3AC307299C8E

P932

Q28297302-873B1B23-7614-4F70-82A1-E391CD7685DE

P3181

P356

S10461-013-0593-Y

P1433

AIDS and Behavior

P1476

Effectiveness of structural-le ...... ect drugs: a systematic review

@en

P2093

Abu S Abdul-Quader

http://www.w3.org/2001/XMLSchema#string

Alya Briceno

http://www.w3.org/2001/XMLSchema#string

Don C Des Jarlais

http://www.w3.org/2001/XMLSchema#string

Ellen S Stein

http://www.w3.org/2001/XMLSchema#string

Gail E Kennedy

http://www.w3.org/2001/XMLSchema#string

Jonathan Feelemyer

http://www.w3.org/2001/XMLSchema#string

Salaam Semaan

http://www.w3.org/2001/XMLSchema#string

Shilpa Modi

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacy-based needle exchange in New Zealand: a review of services.

Optimal provision of needle and syringe programmes for injecting drug users: A systematic review

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

Telaprevir for retreatment of HCV infection

Linking sexual and reproductive health and HIV interventions: a systematic review.

The social structural production of HIV risk among injecting drug users.

Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.

An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA.

P2888

s10461-013-0593-y

P304

2878-2892

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

1084032

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S10461-013-0593-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256102028

http://www.w3.org/2001/XMLSchema#string

P698

23975473

http://www.w3.org/2001/XMLSchema#string

P932

6509353

http://www.w3.org/2001/XMLSchema#string